Stockholders’ Equity (Deficit) |
9 Months Ended |
|---|---|
May 31, 2026 | |
| Equity [Abstract] | |
| Stockholders’ Equity (Deficit) | Note 3 – Stockholders’ Equity (Deficit)
Authorized Shares
The Company is authorized to issue up to 1,800,000,000 shares of common stock par value $0.0001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights. The Company’s initial Articles authorized 5,000,000 preferred shares at 0.0001 par value, no other attributes have been assigned and no such shares have ever been issued.
Common Stock
The Company is authorized to issue up to 1,800,000,000 shares of common stock, par value $0.0001 per share. There is also 5,000,000 shares of Preferred stock, none of which has been issued. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights.
During the period ended May 31, 2026, the company issued 921,805,889 shares as a result of conversion of a loan and interest at a total of $148,561.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|